Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2023-11-06 Director's Dealing
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
112年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their family members. It shows changes in share ownership, types of shares held, and other related data. There is no indication of financial statements, earnings data, or meeting materials. The content is focused on insider share transactions and holdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2023-11-06 Chinese
112年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors and senior management. It lists individual holdings, pledged shares, and related party holdings. The content focuses on insider share transactions and holdings rather than financial results, governance policies, or meeting materials. There is no indication of a report publication, earnings release, or regulatory certification. The document is a typical insider shareholding disclosure, which aligns with the category for Director's Dealing (DIRS). The document length is short (2484 characters), consistent with a disclosure rather than a full report. Therefore, the best classification is Director's Dealing (DIRS).
2023-11-06 Chinese
112年第3季海外子公司投資
Regulatory Filings Classification · 90% confidence The document contains financial data related to investment in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for the current period. The data is presented in a tabular format with notes explaining accounting treatments. The document length is short (662 characters) and appears to be a periodic financial disclosure rather than a full annual or quarterly report. There is no indication that this is an announcement of a report publication or a certification. The content aligns with a regulatory filing providing investment details, likely a routine disclosure under securities regulations. Given the lack of comprehensive financial statements or management discussion, and the nature of the data, the best fit is Regulatory Filings (RNS).
2023-11-03 Chinese
112年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory approval limits. The content is focused on investment details rather than a full financial report or announcement. The document length is short (1287 characters), but it contains substantive financial data related to investments, not just an announcement or certification. This type of disclosure aligns with regulatory filings related to investment information, which do not fit into other specific categories like Annual Report or Interim Report. Therefore, the best classification is Regulatory Filings (RNS), as it is a general regulatory disclosure about investment activities without being a full report or announcement of a report.
2023-11-03 Chinese
112年第3季財務報告書 — 202304_1786_AIC.pdf
Audit Report / Information Classification · 95% confidence The document is titled 'Parent Company Only Financial Statements and Independent Auditors' Report' for the years ended December 31, 2023 and 2022. It contains an independent auditor's opinion, audit basis, key audit matters, responsibilities of management and auditors, and detailed financial statements including balance sheets and notes. The content is a full audit report with financial data and disclosures, not merely an announcement or certification. The presence of detailed financial statements and auditor's report indicates this is a standalone audit report rather than a full annual report or other filing. Therefore, the document fits the definition of an Audit Report / Information (AR). FY 2023
2023-11-03 Chinese
112年第3季財務報告書 — 202304_1786_AIA.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'Consolidated Financial Statements and Independent Auditors' Report For the Years Ended December 31, 2023 and 2022' and contains detailed auditor's opinion, audit scope, key audit matters, and consolidated financial statements including balance sheets and notes. It is a full audit report with comprehensive financial data and disclosures for the fiscal years mentioned. The presence of an independent auditor's report and detailed financial statements indicates this is a standalone audit report rather than a full annual report or a brief announcement. The document length (15,000 characters) and content confirm it is not a short announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2023
2023-11-03 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.